AI-generated summary
The authors report a prospective observational study of 25 women with facial melasma treated with three sessions of a new 675 nm laser system. Melasma severity scores improved significantly at three months after the last session, and the authors describe minor erythematous reactions in two patients. The study included a preclinical sheep skin component and was observational without a control group.
- Participants
- 25
- Who or what was studied
- 25 women aged 21 to 50 years with facial melasma and Fitzpatrick skin types I to III
- Wavelengths
- 675 nm
- Limits stated in the abstract
- The study is observational with a small sample, and the abstract reports no control group; the preclinical component was conducted in sheep skin.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 675 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Observational study, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.